2019 Agenda

Keynotes

    • Keynote
Drive purpose-driven business model changes for 2025
  • Determine how to cope with new changes and challenges to enable new growth
  • Determine what should be outsourced and what should be nurtured internally
  • One size doesn’t fit all: Design your treatment program according to patient symptoms and needs through more personalised models
    • Keynote
PANEL DISCUSSION: Turning RWD into a strategic asset leveraging a collaboration platform
  • With an unprecedented amount of data becoming available internally and externally, explore ways to best capture the required data to turn it into a strategic asset that generates meaningful insights for accelerated R&D innovation, market access and better patient engagement
  • Examine how to tackle key challenges the industry is facing for RWD usability
  • Share leading practices of building a collaborative network among the industry, leading medical institutions and academia around oncology, leveraging ‘DoubleJump™ Interchange’, a leading real-world data platform
    • Keynote
Tomorrow’s winner will prioritise innovation – and inspire the workforce
  • Nurture leaders that set challenging goals and inspire staff to perform
  • Learn how to improve employee productivity by encouraging intellectual curiosity
  • Facilitate internal cross collaboration in a matrixial environment
    • Keynote
Foster more transparent partnerships with government bodies
  • Understand bilateral needs and respond to mutual expectations for Japanese citizens
  • Predict the changing healthcare needs to foresee medical and pricing policy for 2025 and equip your internal teams accordingly
  • Take a look at 'future benchmark' regulatory affairs, the healthcare insurance system and personal information protection laws for data privacy
    • Keynote
Relaunch your business based on a new partnership model of transparency between pharma and patient
  • Build a patient engagement framework that can be applied across your company and yet ensure compliance
  • Connect the JPMA and patient groups for better understanding and partnerships
  • Generate valuable patient insights from an early stage to serve patients better and generate greater trust
    • Keynote
New models of care delivery: Learn the personalised approach from rare disease
  • Harness deeper strategic thinking for personalised customer interaction
  • Meet the medical needs of your customer (patients and doctors) for swift correspondence
  • Explore how to accelerate value of the communication with less face-to-face time
  • Build a system that identifies individuals rather than disease group
    • Keynote
Turning point in pricing: The case for price optimization models
  • Understand how global government bodies aim to reduce healthcare costs but ensure the most valuable drugs continue to be distributed based on real evidence
    • Keynote
Build your reputation: Embrace the patient’s emotional response as your key business focus
  • Address the fundamental issues around patient engagement
  • Reassess the service for patients that eases burden and benefits patients
  • Adopt patient engagement that naturally provides better data gathering and greater insights
  • Rethink how patients want to be communicated to – what is the optimum means?
    • Keynote
PANEL DISCUSSION: Shift from competition to collaboration with other pharma firms
  • Identify Japanese pharma’s priorities and critical activities until 2025 to ensure effectiveness in your future plan
  • Reduce inefficiencies by ensuring individual teams are allocated joint responsibilities with competitors to focus on what’s best for customers
  • Learn from international experience: fill in the gaps and identify opportunities for strategic advantage
    • Keynote
Create a pro-active partnership strategy to ensure high quality drugs reach the patients in need
  • Grasp why pre-competitive work enables you to raise the tide for all, avoiding power games while prioritising patients
  • Set new goals and ambition to motivate the industry to help patients receive drugs and solutions in a timely manner

Commercial track

Section 1: Innovate for systemic change: Reform your approach to meet elevated customer expectations and remove internal silos

    • Commercial
The changing face of commercial excellence: ensure your limited resources are deployed for maximum impact
  • Determine the direction of the evolution for your sales reps by using predictive analytics to see how targeted and localised they will become
  • Understand why marketing departments will become more strategic, with basic work determined by analytics and AI
  • Identify customer trends: Be more adaptive and tuned-in to the changing needs of doctors
    • Commercial
PANEL DISCUSSION: Radically rethink your service to gain doctor’s trust: To make patients happy, doctors need to be happy
  • Address the benefits and challenges of more online drug information
  • Eliminate doctor’s work burdens, then support and connect with their aspirations and career development
    • Commercial
Integrate your commercial functions to enable your organisation to meet elevated customer expectations
  • Identify which commercial channels should be combined to deliver holistic services to customers
  • Bridge the gap between your sales and marketing functions for transparency and collaboration
  • Address increasingly challenging environment and leverage your current resource

Section 2: Harness the data opportunity: Unlock the potential of commercial data to really understand physicians and patients

    • Commercial
Leverage commercial data through integration, optimisation and automation
  • Unlock future commercial advantages through better integration of medical data during early planning
  • Unite structured and unstructured data: Integrate internally collected data and externally provided data for a panoptic result
  • Explore different data analysis techniques depending on your company’s objectives and wider strategy
    • Commercial
Data-driven Customer Centricity: the Key to Increased Competitiveness
  • Grasp the value of data-driven customer centricity and to what extent can it contribute to increased competitiveness
  • Understand the building blocks of a data-driven customer centric strategy and how can it be implemented
  • Explore how advanced analytical techniques such as AI and Machine Learning can contribute to a more customer centric way of interaction between HCPs and pharma companies
    • Commercial
Enhance your CRM system through data integration to overcome limited face-to-face time with doctors
  • Segment your activity according to variations in doctor behaviour using insight-based analysis
  • Harness sales figures and specific field activity data in a system for MRs to maximise their visit opportunity
  • Compile customer data to provide preferential and beneficial information to physicians

Section 3: Prepare for the future: Fundamentally rethink your sales roles to create effective and trusted sales teams

    • Commercial
Consider the balance between using internal and external resources, for better adaptability
  • Underline the pros and cons of investing in a flexible external MR field force
  • The balance between internal investment and external risk: identify what can be outsourced and what cannot
  • How to train and motivate your external resources to bring in revenue
    • Commercial
Identify the capabilities and attitudes needed to build the next-generation sales force
  • Become your doctor’s desire: Manage HCP’s unmet needs by using your field information gathered by MRs
  • The next-generation sales force: collect customer data to improve information quality and replan your MR’s roles
  • Maximise the utility of existing MRs through retraining and inspiring new objectives
    • Commercial
Collaborate with stakeholders to deliver an area-specific sales approach
  • Align with wholesalers to map specific areas and localise your sales approach
  • Implement a remote detailing platform to engage with doctors efficiently and effectively
  • Manage your area representatives: optimise coaching for small teams of MRs who work remotely

Section 4: No more silos: Redefine your commercial model to encourage integration

    • Commercial
Develop a distinctive launch strategy: Segment and cluster your resources for effective marketing
  • Understand changing customer needs according to the characteristics of the disease, the current cure and unmet medical needs
  • Efficient but effective marketing: Group clusters into the finer level in order to successfully position your drug
  • Determine your roadmap for the next 2 years: Craft a system which delivers messages combined with evidence that the drug works for specific patients
    • Commercial
New life for older products: how to maximise late-stage primary care
  • Monitor real world feedback to create a deeper understanding of the emotional element of the drugs your patients use
  • Differentiate your marketing strategy at different points during the drug’s lifecycle by carefully assessing your population needs
  • Shift towards a high potential market and win your customers from your competitors

Section 5: From awareness to action! Use digital to go beyond simply informing customers, and generate sales

    • Commercial
Improve your ROI with digital channels: Move from product acknowledgment to translating to sales
  • Examine new digital models which provide in-depth information via new channels
  • Create a campaign that acts quickly on changing customer insights and adapt your engagement plans in real-time
  • Accelerate digital interactions with your customer to increase ROI
    • Commercial
Pharma vs the rest of the world: An external view of our industry’s relative performance in becoming a trusted partner
  • A look at the optimum ways to meet service and efficiency challenges across multiple channels with in-house and external digital marketing sources
  • Close the digital gap: Provide tailored care around your customer
  • Specific learnings from technology and B2C companies that could advance pharma’s future communication strategy

RWE & Data

SECTION 1: Your data journey: Build a value-based healthcare model which ensures future sustainability and prosperity

    • RWE & Data
Recognise that the optimal future of medical care requires working not just for patients, but with patients
  • Create a real partnership to ensure access is based on high quality data and the voice of patients
  • Demonstrate patient outcomes, by using data, to determine value both inside and beyond your company walls
  • Understand the most effective ways to capture patient needs and stories, including how information is gathered and treatments are selected
    • RWE & Data
Create a value-based blueprint for your company
  • Explore why the patient’s lifetime medical record is a key tool for establishing a higher standard of medical care
  • Take a fresh look at dormant academia data, improving access to medical databases and building RWD infrastructure in order to visualise the patient journey
  • Hear an expert perspective on reconciling the Act of the Next Generation Medical Infrastructure and handling personal information to recognize the limits of prescription and connected data
  • Discuss how to use data to improve the quality of medical care to offer more value to patients

SECTION 2: Fit for purpose: Set higher RWE quality standards in order to bring clarity and confidence to decisions which engender stakeholder trust

    • RWE & Data
Back to basics: The kinds of real world data and their appropriate use
  • Understand the fundamental kind of data to know when to reconsider your plan
  • Explore how to use medical RWD in areas such as descriptive epidemiology, outcome research, PMS and HEOR
    • RWE & Data
The importance of access to data in informing clinical practice – from safety, efficacy and affordability to epidemiology
  • Explore how Medical Affairs can tackle the 5th hurdle (“informing clinical practice”) with data generation
  • Discover how MSD uses existing real-world and newly available databases to demonstrate value and create trust whilst addressing their limitations
  • The National Database (NDB): explore its potential, risks and limitations.
  • Integrity is vital: Develop a framework in co-operation with stakeholders in order to gain trust – and make good use of Medical Affairs' unbiased, scientific-based nature
    • RWE & Data
Use Real World data for clinical development and safety validation post-market surveillance
  • Examine how to use Real World Data for clinical development
  • Learn about safety assessment using Real World Data - including MID-NET - for post-market pharmacovigilance
    • RWE & Data
Promote the use of the disease registry system (patient registry) to contribute to clinical trials and research
  • Grasp the current state of academic data with an outline of the Clinical Innovation Network
  • Take a look at case studies of muscular disease to learn how the registry can be leveraged to promote clinical development
  • As the number of disease areas increases, understand the role pharma should play and how the disease registry can be expanded
  • Examine the disease registry in light of new pharmaceutical affairs law

SECTION 3: Redesign your go-to-market model: Ensure your commercial endeavours are well-informed by excellent use of RWE

    • RWE & Data
Form a robust corporate structure, centered on RWE
  • Determine how each division should function and cooperate to align with real world data objectives
  • Grasp company needs alongside the latest RWD information in order to create a corporate structure that uses RWD to achieve objectives
  • Recognise the importance of forming long-term partnerships with vendors in data sourcing
    • RWE & Data
Pre-competition: Alignment for faster progress
  • Master the art of successful partnership-building for an efficient drug discovery database containing clinical research data
  • Locate overlapping processes to cut waste in the data collection phase

SECTION 4: Beyond the pill: Find opportunities to create new value in our evolving data environment

    • RWE & Data
An improved pharma company reputation, brought about by mobile technology
  • The era of developing and selling medicine is over
  • Create a strategy for using mobile technology in pharma companies
  • Examine the hurdles to implementing advanced technology for the good of society
    • RWE & Data
Determine the best combination of digital tools and medicines to generate the greatest cancer treatment outcomes
  • Learn about digital tools which facilitate stronger patient-physician communication in order to improve the QOL of cancer patients
  • Explore how Novartis use these tools to improve continuous long term cancer treatments, following prognosis
    • RWE & Data
Optimise the best combination of digital tools and physical medicine to generate the greatest outcomes
  • Learn about digital medicines which improve patient QOL and which gather data to save patients in future
  • Gain a competitive advantage in digital solutions: learn about new therapeutic mobile apps which redefine the relationship between pharma companies and patients

Commercial Roundtables

    • Commercial Roundtables
Design a data-driven strategy that enables evidence-based decision-making

Understand how to amplify your data resources to enable a genuine evolution of your commercial activities and smartly use the data you already have, rather than relentlessly focussing on acquiring more data

    • Commercial Roundtables
Turn data insights into action

Identify the risks and find solutions to overcome the hurdles to gain patient and doctor data then, design goals and metrics with achievable targets for reliable and repeatable data

    • Commercial Roundtables
Unrivalled digital driven insight through a solid data insight

Learn how to introduce digital change for your customers to smoothly embrace and make it easier for decision making by creating a strong digital platform foundation.

    • Commercial Roundtables
Meet customer needs to deliver excellence in each region

Discuss ways to build area specific regional formulary by thoroughly understanding the area, engage with local authorities to provide a dedicated approach.

    • Commercial Roundtables
Maximise the utility of existing MRs through retraining and inspiring new objectives

Identify the unique value that MRs can provide and combine this with specific channels to extend valuable information to your customers

RWE Roundtables

    • RWE Roundtables
Expand your available methods of data-gathering

Understand the wider needs of society in order to develop your own research purpose and define your data-pool.

    • RWE Roundtables
Deploy RWE successfully

Understand a patient’s QOL and predict patient outcomes to learn how you can indicate the impact of disease by evidence generation.

    • RWE Roundtables
Nurture future data leaders

Discuss how to tackle the shortage of talent andthe best ways to nurture young talent to secure their future within the data field

    • RWE Roundtables
Harness the potential of RWE to build an effective corporate structure

Discuss the best way to deploy RWE in your company to enable effective management, education and cost savings

    • RWE Roundtables
Expand disease registries by collaborating with academia

Discuss the role that pharma should take and the relationship with academia when increasing registries in new disease areas to maximize the results.

Keynotes

    • Keynote
Drive purpose-driven business model changes for 2025
  • Determine how to cope with new changes and challenges to enable new growth
  • Determine what should be outsourced and what should be nurtured internally
  • One size doesn’t fit all: Design your treatment program according to patient symptoms and needs through more personalised models
    • Keynote
PANEL DISCUSSION: Turning RWD into a strategic asset leveraging a collaboration platform
  • With an unprecedented amount of data becoming available internally and externally, explore ways to best capture the required data to turn it into a strategic asset that generates meaningful insights for accelerated R&D innovation, market access and better patient engagement
  • Examine how to tackle key challenges the industry is facing for RWD usability
  • Share leading practices of building a collaborative network among the industry, leading medical institutions and academia around oncology, leveraging ‘DoubleJump™ Interchange’, a leading real-world data platform
    • Keynote
Tomorrow’s winner will prioritise innovation – and inspire the workforce
  • Nurture leaders that set challenging goals and inspire staff to perform
  • Learn how to improve employee productivity by encouraging intellectual curiosity
  • Facilitate internal cross collaboration in a matrixial environment
    • Keynote
Foster more transparent partnerships with government bodies
  • Understand bilateral needs and respond to mutual expectations for Japanese citizens
  • Predict the changing healthcare needs to foresee medical and pricing policy for 2025 and equip your internal teams accordingly
  • Take a look at 'future benchmark' regulatory affairs, the healthcare insurance system and personal information protection laws for data privacy
    • Keynote
Relaunch your business based on a new partnership model of transparency between pharma and patient
  • Build a patient engagement framework that can be applied across your company and yet ensure compliance
  • Connect the JPMA and patient groups for better understanding and partnerships
  • Generate valuable patient insights from an early stage to serve patients better and generate greater trust
    • Keynote
New models of care delivery: Learn the personalised approach from rare disease
  • Harness deeper strategic thinking for personalised customer interaction
  • Meet the medical needs of your customer (patients and doctors) for swift correspondence
  • Explore how to accelerate value of the communication with less face-to-face time
  • Build a system that identifies individuals rather than disease group
    • Keynote
Turning point in pricing: The case for price optimization models
  • Understand how global government bodies aim to reduce healthcare costs but ensure the most valuable drugs continue to be distributed based on real evidence
    • Keynote
Build your reputation: Embrace the patient’s emotional response as your key business focus
  • Address the fundamental issues around patient engagement
  • Reassess the service for patients that eases burden and benefits patients
  • Adopt patient engagement that naturally provides better data gathering and greater insights
  • Rethink how patients want to be communicated to – what is the optimum means?
    • Keynote
PANEL DISCUSSION: Shift from competition to collaboration with other pharma firms
  • Identify Japanese pharma’s priorities and critical activities until 2025 to ensure effectiveness in your future plan
  • Reduce inefficiencies by ensuring individual teams are allocated joint responsibilities with competitors to focus on what’s best for customers
  • Learn from international experience: fill in the gaps and identify opportunities for strategic advantage
    • Keynote
Create a pro-active partnership strategy to ensure high quality drugs reach the patients in need
  • Grasp why pre-competitive work enables you to raise the tide for all, avoiding power games while prioritising patients
  • Set new goals and ambition to motivate the industry to help patients receive drugs and solutions in a timely manner

Commercial Roundtables

    • Commercial Roundtables
Design a data-driven strategy that enables evidence-based decision-making

Understand how to amplify your data resources to enable a genuine evolution of your commercial activities and smartly use the data you already have, rather than relentlessly focussing on acquiring more data

    • Commercial Roundtables
Turn data insights into action

Identify the risks and find solutions to overcome the hurdles to gain patient and doctor data then, design goals and metrics with achievable targets for reliable and repeatable data

    • Commercial Roundtables
Unrivalled digital driven insight through a solid data insight

Learn how to introduce digital change for your customers to smoothly embrace and make it easier for decision making by creating a strong digital platform foundation.

    • Commercial Roundtables
Meet customer needs to deliver excellence in each region

Discuss ways to build area specific regional formulary by thoroughly understanding the area, engage with local authorities to provide a dedicated approach.

    • Commercial Roundtables
Maximise the utility of existing MRs through retraining and inspiring new objectives

Identify the unique value that MRs can provide and combine this with specific channels to extend valuable information to your customers

RWE Roundtables

    • RWE Roundtables
Expand your available methods of data-gathering

Understand the wider needs of society in order to develop your own research purpose and define your data-pool.

    • RWE Roundtables
Deploy RWE successfully

Understand a patient’s QOL and predict patient outcomes to learn how you can indicate the impact of disease by evidence generation.

    • RWE Roundtables
Nurture future data leaders

Discuss how to tackle the shortage of talent andthe best ways to nurture young talent to secure their future within the data field

    • RWE Roundtables
Harness the potential of RWE to build an effective corporate structure

Discuss the best way to deploy RWE in your company to enable effective management, education and cost savings

    • RWE Roundtables
Expand disease registries by collaborating with academia

Discuss the role that pharma should take and the relationship with academia when increasing registries in new disease areas to maximize the results.

Commercial track

Section 1: Innovate for systemic change: Reform your approach to meet elevated customer expectations and remove internal silos

    • Commercial
The changing face of commercial excellence: ensure your limited resources are deployed for maximum impact
  • Determine the direction of the evolution for your sales reps by using predictive analytics to see how targeted and localised they will become
  • Understand why marketing departments will become more strategic, with basic work determined by analytics and AI
  • Identify customer trends: Be more adaptive and tuned-in to the changing needs of doctors
    • Commercial
PANEL DISCUSSION: Radically rethink your service to gain doctor’s trust: To make patients happy, doctors need to be happy
  • Address the benefits and challenges of more online drug information
  • Eliminate doctor’s work burdens, then support and connect with their aspirations and career development
    • Commercial
Integrate your commercial functions to enable your organisation to meet elevated customer expectations
  • Identify which commercial channels should be combined to deliver holistic services to customers
  • Bridge the gap between your sales and marketing functions for transparency and collaboration
  • Address increasingly challenging environment and leverage your current resource

Section 2: Harness the data opportunity: Unlock the potential of commercial data to really understand physicians and patients

    • Commercial
Leverage commercial data through integration, optimisation and automation
  • Unlock future commercial advantages through better integration of medical data during early planning
  • Unite structured and unstructured data: Integrate internally collected data and externally provided data for a panoptic result
  • Explore different data analysis techniques depending on your company’s objectives and wider strategy
    • Commercial
Data-driven Customer Centricity: the Key to Increased Competitiveness
  • Grasp the value of data-driven customer centricity and to what extent can it contribute to increased competitiveness
  • Understand the building blocks of a data-driven customer centric strategy and how can it be implemented
  • Explore how advanced analytical techniques such as AI and Machine Learning can contribute to a more customer centric way of interaction between HCPs and pharma companies
    • Commercial
Enhance your CRM system through data integration to overcome limited face-to-face time with doctors
  • Segment your activity according to variations in doctor behaviour using insight-based analysis
  • Harness sales figures and specific field activity data in a system for MRs to maximise their visit opportunity
  • Compile customer data to provide preferential and beneficial information to physicians

Section 3: Prepare for the future: Fundamentally rethink your sales roles to create effective and trusted sales teams

    • Commercial
Consider the balance between using internal and external resources, for better adaptability
  • Underline the pros and cons of investing in a flexible external MR field force
  • The balance between internal investment and external risk: identify what can be outsourced and what cannot
  • How to train and motivate your external resources to bring in revenue
    • Commercial
Identify the capabilities and attitudes needed to build the next-generation sales force
  • Become your doctor’s desire: Manage HCP’s unmet needs by using your field information gathered by MRs
  • The next-generation sales force: collect customer data to improve information quality and replan your MR’s roles
  • Maximise the utility of existing MRs through retraining and inspiring new objectives
    • Commercial
Collaborate with stakeholders to deliver an area-specific sales approach
  • Align with wholesalers to map specific areas and localise your sales approach
  • Implement a remote detailing platform to engage with doctors efficiently and effectively
  • Manage your area representatives: optimise coaching for small teams of MRs who work remotely

Section 4: No more silos: Redefine your commercial model to encourage integration

    • Commercial
Develop a distinctive launch strategy: Segment and cluster your resources for effective marketing
  • Understand changing customer needs according to the characteristics of the disease, the current cure and unmet medical needs
  • Efficient but effective marketing: Group clusters into the finer level in order to successfully position your drug
  • Determine your roadmap for the next 2 years: Craft a system which delivers messages combined with evidence that the drug works for specific patients
    • Commercial
New life for older products: how to maximise late-stage primary care
  • Monitor real world feedback to create a deeper understanding of the emotional element of the drugs your patients use
  • Differentiate your marketing strategy at different points during the drug’s lifecycle by carefully assessing your population needs
  • Shift towards a high potential market and win your customers from your competitors

Section 5: From awareness to action! Use digital to go beyond simply informing customers, and generate sales

    • Commercial
Improve your ROI with digital channels: Move from product acknowledgment to translating to sales
  • Examine new digital models which provide in-depth information via new channels
  • Create a campaign that acts quickly on changing customer insights and adapt your engagement plans in real-time
  • Accelerate digital interactions with your customer to increase ROI
    • Commercial
Pharma vs the rest of the world: An external view of our industry’s relative performance in becoming a trusted partner
  • A look at the optimum ways to meet service and efficiency challenges across multiple channels with in-house and external digital marketing sources
  • Close the digital gap: Provide tailored care around your customer
  • Specific learnings from technology and B2C companies that could advance pharma’s future communication strategy

RWE & Data

SECTION 1: Your data journey: Build a value-based healthcare model which ensures future sustainability and prosperity

    • RWE & Data
Recognise that the optimal future of medical care requires working not just for patients, but with patients
  • Create a real partnership to ensure access is based on high quality data and the voice of patients
  • Demonstrate patient outcomes, by using data, to determine value both inside and beyond your company walls
  • Understand the most effective ways to capture patient needs and stories, including how information is gathered and treatments are selected
    • RWE & Data
Create a value-based blueprint for your company
  • Explore why the patient’s lifetime medical record is a key tool for establishing a higher standard of medical care
  • Take a fresh look at dormant academia data, improving access to medical databases and building RWD infrastructure in order to visualise the patient journey
  • Hear an expert perspective on reconciling the Act of the Next Generation Medical Infrastructure and handling personal information to recognize the limits of prescription and connected data
  • Discuss how to use data to improve the quality of medical care to offer more value to patients

SECTION 2: Fit for purpose: Set higher RWE quality standards in order to bring clarity and confidence to decisions which engender stakeholder trust

    • RWE & Data
Back to basics: The kinds of real world data and their appropriate use
  • Understand the fundamental kind of data to know when to reconsider your plan
  • Explore how to use medical RWD in areas such as descriptive epidemiology, outcome research, PMS and HEOR
    • RWE & Data
The importance of access to data in informing clinical practice – from safety, efficacy and affordability to epidemiology
  • Explore how Medical Affairs can tackle the 5th hurdle (“informing clinical practice”) with data generation
  • Discover how MSD uses existing real-world and newly available databases to demonstrate value and create trust whilst addressing their limitations
  • The National Database (NDB): explore its potential, risks and limitations.
  • Integrity is vital: Develop a framework in co-operation with stakeholders in order to gain trust – and make good use of Medical Affairs' unbiased, scientific-based nature
    • RWE & Data
Use Real World data for clinical development and safety validation post-market surveillance
  • Examine how to use Real World Data for clinical development
  • Learn about safety assessment using Real World Data - including MID-NET - for post-market pharmacovigilance
    • RWE & Data
Promote the use of the disease registry system (patient registry) to contribute to clinical trials and research
  • Grasp the current state of academic data with an outline of the Clinical Innovation Network
  • Take a look at case studies of muscular disease to learn how the registry can be leveraged to promote clinical development
  • As the number of disease areas increases, understand the role pharma should play and how the disease registry can be expanded
  • Examine the disease registry in light of new pharmaceutical affairs law

SECTION 3: Redesign your go-to-market model: Ensure your commercial endeavours are well-informed by excellent use of RWE

    • RWE & Data
Form a robust corporate structure, centered on RWE
  • Determine how each division should function and cooperate to align with real world data objectives
  • Grasp company needs alongside the latest RWD information in order to create a corporate structure that uses RWD to achieve objectives
  • Recognise the importance of forming long-term partnerships with vendors in data sourcing
    • RWE & Data
Pre-competition: Alignment for faster progress
  • Master the art of successful partnership-building for an efficient drug discovery database containing clinical research data
  • Locate overlapping processes to cut waste in the data collection phase

SECTION 4: Beyond the pill: Find opportunities to create new value in our evolving data environment

    • RWE & Data
An improved pharma company reputation, brought about by mobile technology
  • The era of developing and selling medicine is over
  • Create a strategy for using mobile technology in pharma companies
  • Examine the hurdles to implementing advanced technology for the good of society
    • RWE & Data
Determine the best combination of digital tools and medicines to generate the greatest cancer treatment outcomes
  • Learn about digital tools which facilitate stronger patient-physician communication in order to improve the QOL of cancer patients
  • Explore how Novartis use these tools to improve continuous long term cancer treatments, following prognosis
    • RWE & Data
Optimise the best combination of digital tools and physical medicine to generate the greatest outcomes
  • Learn about digital medicines which improve patient QOL and which gather data to save patients in future
  • Gain a competitive advantage in digital solutions: learn about new therapeutic mobile apps which redefine the relationship between pharma companies and patients
I want to attend I want the Brochure